Skip to content

Reducing Wound Infections Using Bioelectric Wound Dressings

Reducing Wound Infections Using Bioelectric Wound Dressings

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06312267
Acronym
JumpStart
Enrollment
20
Registered
2024-03-15
Start date
2024-03-04
Completion date
2025-03-01
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infection

Keywords

Surgery outcomes, Bioelectric dressing,

Brief summary

The purpose of this study is to compare the outcomes of using Bioelectric wound dressing on the pre-operative wound site and post operatively and compared it outcomes to the standard of care chlorhexidine skin preparation.

Detailed description

The standard of care for enhance recovery after surgery (ERAS) protocol uses chlorhexidine alcohol base prep as the way to clean the skin preoperatively to decrease bacterial flora before sterile prep at the OR. Under ERAS protocol there is no recommendations on any post-operative dressing. Biolelectric wound dressing has been introduced, used and proof to decrease wound infection in orthopedic extremity clean surgery for years. The purpose of this study is to compare the outcomes of using Bioelectric wound dressing on the pre-operative wound site and post operatively and compared it outcomes to the standard of care chlorhexidine skin preparation.

Interventions

Participants randomized into the experimental arm will have a bioelectric dressing applied 3 days before surgery, and 3 days post-surgery.

Sponsors

AdventHealth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Total of 20 patients will be identified and divided in two groups (control and experimental group). 10 of the patients undergo surgery using current ERAS protocol standard of care skin cleaning preparation. The other 10 patients skin prep will be substituted with the Bioelectrical dressing preoperatively and post-operative.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Elective diverticular, benign polyp, or colon cancer resection 2. Age 18-90 years old 3. All patients must receive some kind of bowel prep (SU- prep, pills, Go-Lytely, milk of magnesia, etc.…) 4. Must be off antibiotics for more than 2 weeks before surgery 5. Surgery must be laparoscopic, hand assisted or Robotic 6. Skin will be closed in layers and subcuticular interrupted fashion 7. Just one dose of preoperative antibiotics (Invanz or equivalent if patient is allergic) 8. Patients will have a primary anastomosis, no colostomy. 9. Patient must be compliant with dressing care 10. Ability to provide informed consent

Exclusion criteria

1. Active infections before surgery -example: Intra-abdominal abscess not drained or actively on antibiotics on the day of surgery, skin infections 2. Inability to take intestinal bowel preparation 3. HgbA1c \>8 4. BMI \>40 5. Immunosuppression 6. Need of steroid stress dose pre-op 7. Patient receiving active chemotherapy 8. Need of stoma (end ostomies after resection protective stoma included) 9. Need of blood transfusion during surgery 10. Use of irrigation with antibiotics or IRRISEPTR during surgery 11. Any standard contraindication to anesthesia and/or surgery 12. Pregnancy or lactating women 13. Inability to provide informed consent 14. Inability to follow instructions for dressing care 15. Sensitivity or allergy to silver or zinc

Design outcomes

Primary

MeasureTime frameDescription
Quantitative bacterial count4 total biopsies will be collected. (3 days before surgery, surgery day pre incision, immediately post-surgery and 3 days post-surgery)Skin biopsies will be collected and analyzed for bacterial counts

Countries

United States

Contacts

Primary ContactPetronio Martins, MHA
Petronio.martins@adventhealth.com407-303-5503
Backup ContactDiana Paredes, BSN
Diana.Paredes@adventhealth.com407-303-55-03

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026